About
Ophthalmology Treatments
Areas of Focus
Categories
Small Molecule PharmaceuticalSan Diego & Southern California
Clinical Trials (10)
View allTotal Trials
10
As Lead Sponsor
8
As Collaborator
2
Total Enrollment
1,616
By Phase
PHASE1: 2PHASE3: 4PHASE2: 4
By Status
COMPLETED: 10
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06270030Collaborator
Safety, Tolerability and Pharmacokinetics of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Chinese With Presbyopia
PHASE1Completed
21 participants
Started: Mar 4, 2024 · Completed: Apr 10, 2024
NCT06045299Collaborator
Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia
PHASE3Completed
300 participants
Started: Sep 27, 2023 · Completed: Jan 27, 2025
NCT05936489Lead Sponsor
Plasma Pharmacokinetics and Safety of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With Presbyopia
PHASE1Completed
30 participants
Started: Jul 6, 2023 · Completed: Oct 3, 2023
NCT05728944Lead Sponsor
Phase 3 Efficacy Study of LNZ101 for the Treatment of Presbyopia
PHASE3Completed
229 participants
Started: Mar 6, 2023 · Completed: Jan 24, 2024
NCT05753189Lead Sponsor
Phase 3 Safety Study for the Treatment of Presbyopia Subjects
PHASE3Completed
362 participants
Started: Feb 21, 2023 · Completed: Feb 9, 2024
Locations (1)
Headquarters
Del Mar, CA, United States
Map
Loading map...